hotspot -WSS

hotspot

author：entertainment 2025-08-26 02:45:31 - browse：18336

AI skin cancer detector, dermasensor. -- health tech coverage from STAT — Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： New England Journal of Medicine addresses racist history, slavery

hotspot

WSS

Young boy dies in trial for Pfizer Duchenne gene therapy

Young boy dies in trial for Pfizer Duchenne gene therapy

First Opinion on colorectal cancer screening: letter and response

Republican states more likely to report Covid vaccine side effects

New menopause drug shows promise in relief for hot flashes

Heart disease and mental health: A look at cardiac psychology

hotspot

hotspot

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Florida Supreme Court upholds state's abortion ban

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Malaria cases in Florida and Texas: Here’s what you need to know

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Moonlake's readout produced a cash windfall. Risks remain

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Bright Health sells Medicare Advantage business to Molina

Four alarming medical procedures we’re glad history forgot

Wikipedia

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Bird flu reported in person exposed to presumably infected cattle

Oral obesity drug from Viking Therapeutics hits key early target

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Mass General Brigham physicians react to latest merger step

Pancreatic cancer is often deadly, but new discoveries are raising hope

hotspot

knowledge

focus

explore